Nabla Bio
PrivateLast Round
Series C
Jun 17, 2025
Total Funding Raised
$107.38M
Company Overview
Nabla Bio is a biotechnology company that develops an AI-driven platform for the rational design of developable, selective, and functional antibody therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nabla Bio Comparables
Compare Nabla Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BigHat Biosciences | 89% | |
| Evozyne | 85% | |
| EvolutionaryScale | 85% |
Nabla Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 17, 2025 | ||||
| Series A | May 14, 2024 | ||||
| Seed | Dec 6, 2021 | ||||
| Grant | Apr 1, 2021 | ||||
| Accelerator | Aug 24, 2020 |
Nabla Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HV Capital | Series C |
| DST Global | Series C |
| Khosla Ventures | Series A, Seed |
| Cantos Ventures | Seed |
| Zetta Venture Partners | Series A, Seed |
| Pillar VC | Series A, Seed |
| Y Combinator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Received coverage in Science Magazine and Endpoints News.
- Jan 1, 2026
Partnerships disclosed with AstraZeneca, Takeda, and Bristol Myers Squibb.
Nabla Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nabla Bio's valuation, stock price, and market status.
Is Nabla a public or private company?
Nabla is a private company.
What is the current stock price of Nabla?
Nabla is a private company with no public stock price. No recent secondary market data is available.
How much is Nabla worth (valuation)?
Valuation information for Nabla is not publicly available.
Can I buy Nabla stock?
Nabla shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nabla's last funding round?
Nabla's most recent funding round was Series C on June 17, 2025.
Who are the main investors in Nabla?
Key investors in Nabla include HV Capital, Khosla Ventures, Zetta Venture Partners, Radical Ventures.
Will Nabla IPO soon?
No public IPO plans have been announced for Nabla.
How can I track Nabla secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nabla's secondary market activity and sign up for updates.